Home » Topics » Regulatory

Regulatory
RSS

Schering AG's liver-specific contrast agent approved in Sweden

March 30, 2001

Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Cyamemazine reported to successfully substitute for benzodiazepines

March 27, 2001

Pharmaceutical compositions for obstructive airways disorders claimed by AstraZeneca

March 27, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001